Tag: RVP

  • Micro-cap Losers: PC Tel Inc. (NASDAQ:PCTI), Vermillion, Inc. (NASDAQ:VRML), Retractable Technologies, Inc. (NYSEMKT:RVP), OvaScience Inc. (NASDAQ:OVAS), Cerulean Pharma Inc. (NASDAQ:CERU)

    PC Tel Inc. (NASDAQ:PCTI) a leader in simplifying wireless and site solutions for private and public networks, announced on 20 may at Cisco Live! the release of two new directional antennas: the 2.4 GHz and 5 GHz Enclosed Yagi MIMO Antennas for long range broadband wireless access applications. The new yagis provide high-speed directional WiFi coverage and optimized data throughput in a rugged, low profile housing. They are ideal for point-to-point installations in challenging environmental settings such as subways, highways, smart grids, oil and gas fields and wireless backhaul applications. PC Tel Inc. (NASDAQ:PCTI) net profit margin is 3.30% and weekly performance is -7.59%. On last trading day company shares ended up $7.18. Analysts mean target price for the company is $11.50. PC Tel Inc. (NASDAQ:PCTI) distance from 50-day simple moving average (SMA50) is -14.21%.

    Vermillion, Inc. (NASDAQ:VRML) on 15 may posted a loss of $4.2 million in the first quarter, or 11 cents per share, on revenue of $305,000, compared to a loss of $2.6 million, or 17 cents per share, on revenue of $328,000 in the year-earlier period. Vermillion, Inc. (NASDAQ:VRML) shares fell -11.60% in last trading session and ended the day on $2.59. VRML gross Margin is 92.30% and its return on assets is -50.90%.Vermillion, Inc. (NASDAQ:VRML) quarterly performance is -14.80%.

    Retractable Technologies, Inc. (NYSEMKT:RVP) announced on 15 may operating loss was $2.0 million compared to an operating loss for the same period last year of $1.4 million due primarily to lower revenues and higher manufacturing costs. Retractable Technologies, Inc. (NYSEMKT:RVP) shares moved down -6.57% in last trading session and was closed at $2.70, while trading in range of $2.70 – $2.95. Retractable Technologies, Inc. (NYSEMKT:RVP) year to date (YTD) performance is -12.34%.

    Equities research analysts at Oppenheimer initiated coverage on shares of Ovascience (NASDAQ:OVAS) in a research note issued to investors on Tuesday, TheFlyOnTheWall.com reports. The firm set an “outperform” rating and a $11.00 price target on the stock. Oppenheimer’s target price would indicate a potential upside of 37.50% from the company’s current price. OvaScience Inc. (NASDAQ:OVAS) ended the last trading day at $7.14. Company weekly volatility is calculated as 7.22% and price to cash ratio as 1.93.OvaScience Inc. (NASDAQ:OVAS) showed a negative weekly performance of -1.65%.

    Analysts at JMP Securities assumed coverage on shares of Cerulean Pharma (NASDAQ:CERU) in a research report issued to clients and investors on Tuesday, TheFlyOnTheWall.com reports. The firm set an “outperform” rating and a $14.00 price target on the stock. JMP Securities’ price objective indicates a potential upside of 107.72% from the stock’s previous close. Cerulean Pharma Inc. (NASDAQ:CERU) weekly performance is -11.61%. On last trading day company shares ended up $5.71. Analysts mean target price for the company is $12.50. Cerulean Pharma Inc. (NASDAQ:CERU) distance from 50-day simple moving average (SMA50) is -14.75%.